- Title: Subtitle
- PD09-02 ANTI-ADENOVIRAL ANTIBODY LEVELS PREDICT NADOFARAGENE FIRADENOVEC RESPONSE IN BCG-UNRESPONSIVE NMIBC: RESULTS FROM A PHASE 3 TRIAL
- Creators
- Anirban P MitraVikram M NarayanStephen A BoorjianMehrdad AlemozaffarBadrinath R KonetyNeal D ShoreLeonard G GomellaAshish M KamatTrinity J BivalacquaJeffrey S MontgomerySeth P LernerJoseph E BusbyMichael PochPaul L CrispenGary D SteinbergAnne K SchuckmanTracy M DownsRobert S SvatekJoseph MashniBrian R LaneThomas J GuzzoGennady BratslavskyLawrence I KarshMichael E WoodsGordon BrownDaniel CanterAdam LucheyYair LotanTracey KrupskiBrant A InmanMichael B WilliamsMichael S CooksonKirk A KeeganGerald L AndrioleAlexander I SankinAlan BoydMichael A O'DonnellMindy YangDavid SawutzRichard PhilipsonSeppo Ylä-HerttualaNigel R ParkerColin P N Dinney
- Resource Type
- Abstract
- Publication Details
- The Journal of urology, Vol.206(Supplement 3)
- DOI
- 10.1097/JU.0000000000001977.02
- ISSN
- 0022-5347
- eISSN
- 1527-3792
- Language
- English
- Date published
- 09/2021
- Academic Unit
- Urology
- Record Identifier
- 9984321429502771
Abstract
PD09-02 ANTI-ADENOVIRAL ANTIBODY LEVELS PREDICT NADOFARAGENE FIRADENOVEC RESPONSE IN BCG-UNRESPONSIVE NMIBC: RESULTS FROM A PHASE 3 TRIAL
The Journal of urology, Vol.206(Supplement 3)
09/2021
DOI: 10.1097/JU.0000000000001977.02
Details
Metrics
2 Record Views